Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968542957> ?p ?o ?g. }
- W1968542957 endingPage "9543" @default.
- W1968542957 startingPage "9539" @default.
- W1968542957 abstract "The leukocyte NADPH oxidase is an enzyme in phagocytes and B lymphocytes that when activated catalyzes the production of O·̄2 from oxygen and NADPH. During oxidase activation, serine residues in the C-terminal quarter of the oxidase component p47PHOX become extensively phosphorylated, the protein acquiring as many as 9 phosphate residues. In a study of 11 p47PHOX mutants, each containing an alanine instead of a serine at a single potential phosphorylation site, we found that all but S379A corrected the defect in O·̄2 production in Epstein-Barr virus (EBV)-transformed p47PHOX-deficient B cells (Faust, L. P., El Benna, J., Babior, B. M., and Chanock, S. J. (1995)J. Clin. Invest. 96, 1499–1505). In particular, O·̄2 production was restored to these cells by the mutants S303A and S304A. Therefore, apart from serine 379, whose state of phosphorylation in the activated oxidase is unclear, no single potential phosphorylation site appeared to be essential for oxidase activation. We now report that the double mutant p47PHOX S303A/S304A was almost completely inactive when expressed in EBV-transformed p47PHOX-deficient B cells, even though it was expressed in normal amounts in the transfected cells and was able to translocate to the plasma membrane when the cells were stimulated. In contrast, the double mutant p47PHOX S303E/S304E was able to support high levels of O·̄2 production by EBV-transformed p47PHOX-deficient B cells. The surprising discovery that the double mutant S303K/S304K was also able to support considerable O·̄2 production suggests either that the effect of phosphorylation is related to the increase in hydrophilicity around serines 303 and 304 or that activation involves the formation of a metal bridge between the phosphorylated serines and another region of the protein. The leukocyte NADPH oxidase is an enzyme in phagocytes and B lymphocytes that when activated catalyzes the production of O·̄2 from oxygen and NADPH. During oxidase activation, serine residues in the C-terminal quarter of the oxidase component p47PHOX become extensively phosphorylated, the protein acquiring as many as 9 phosphate residues. In a study of 11 p47PHOX mutants, each containing an alanine instead of a serine at a single potential phosphorylation site, we found that all but S379A corrected the defect in O·̄2 production in Epstein-Barr virus (EBV)-transformed p47PHOX-deficient B cells (Faust, L. P., El Benna, J., Babior, B. M., and Chanock, S. J. (1995)J. Clin. Invest. 96, 1499–1505). In particular, O·̄2 production was restored to these cells by the mutants S303A and S304A. Therefore, apart from serine 379, whose state of phosphorylation in the activated oxidase is unclear, no single potential phosphorylation site appeared to be essential for oxidase activation. We now report that the double mutant p47PHOX S303A/S304A was almost completely inactive when expressed in EBV-transformed p47PHOX-deficient B cells, even though it was expressed in normal amounts in the transfected cells and was able to translocate to the plasma membrane when the cells were stimulated. In contrast, the double mutant p47PHOX S303E/S304E was able to support high levels of O·̄2 production by EBV-transformed p47PHOX-deficient B cells. The surprising discovery that the double mutant S303K/S304K was also able to support considerable O·̄2 production suggests either that the effect of phosphorylation is related to the increase in hydrophilicity around serines 303 and 304 or that activation involves the formation of a metal bridge between the phosphorylated serines and another region of the protein. The leukocyte NADPH oxidase is a membrane-associated enzyme in phagocytes and B lymphocytes that catalyzes the production of O·̄2 from oxygen using NADPH as electron donor (1Chanock S.J. el Benna J. Smith R.M. Babior B.M. J. Biol. Chem. 1994; 269: 24519-24522Abstract Full Text PDF PubMed Google Scholar),2O2+NADPH→2O2·¯+NADP++H+Equation 1 Dormant in resting cells, it acquires catalytic activity when the cells are exposed to appropriate stimuli. Activation involves the transfer of cytosolic subunits designated p47PHOX and p67PHOX to the plasma membrane, where they associate with a flavocytochrome known as cytochrome b558 to assemble the active oxidase (2Heyworth P.G. Curnutte J.T. Nauseef W.M. Volpp B.D. Pearson D.W. Rosen H. Clark R.A. J. Clin. Invest. 1991; 87: 352-356Crossref PubMed Scopus (305) Google Scholar). During oxidase activation in whole cells, p47PHOX becomes phosphorylated on numerous serine residues that lie between Ser303 and Ser379 in the C-terminal quarter of this 390-residue molecule (3Hayakawa T. Suzuki K. Suzuki S. Andrews P.C. Babior B.M. J. Biol. Chem. 1986; 261: 9109-9115Abstract Full Text PDF PubMed Google Scholar, 4Ohtsuka T. Okamura N. Ishibashi S. Biochim. Biophys. Acta. 1986; 888: 332-337Crossref PubMed Scopus (40) Google Scholar, 5Caldwell S.E. McCall C.E. Hendricks C.L. Leone P.A. Bass D.A. McPhail L.C. J. Clin. Invest. 1988; 81: 1485-1496Crossref PubMed Scopus (61) Google Scholar, 6Rotrosen D. Leto T.L. J. Biol. Chem. 1990; 265: 19910-19915Abstract Full Text PDF PubMed Google Scholar, 7el Benna J. Faust L.P. Babior B.M. J. Biol. Chem. 1994; 269: 23431-23436Abstract Full Text PDF PubMed Google Scholar). Studies conducted to date have identified the phosphorylated serines (7el Benna J. Faust L.P. Babior B.M. J. Biol. Chem. 1994; 269: 23431-23436Abstract Full Text PDF PubMed Google Scholar, 8Faust L.P. El Benna J. Babior B.M. Chanock S.J. J. Clin. Invest. 1995; 96: 1499-1505Crossref PubMed Scopus (155) Google Scholar, 9El Benna J. Faust L.P. Johnson J.L. Babior B.M. J. Biol. Chem. 1996; 271: 6374-6378Abstract Full Text Full Text PDF PubMed Scopus (207) Google Scholar), examined their susceptibility to phosphorylation by various protein kinases that occur in neutrophils (9El Benna J. Faust L.P. Johnson J.L. Babior B.M. J. Biol. Chem. 1996; 271: 6374-6378Abstract Full Text Full Text PDF PubMed Scopus (207) Google Scholar, 10El Benna J. Han J. Park J.-W. Schmid E. Ulevitch R.J. Babior B.M. Arch. Biochem. Biophys. 1996; 334: 395-400Crossref PubMed Scopus (208) Google Scholar), and shown that in all likelihood no single phosphorylated serine is indispensable for oxidase activity (8Faust L.P. El Benna J. Babior B.M. Chanock S.J. J. Clin. Invest. 1995; 96: 1499-1505Crossref PubMed Scopus (155) Google Scholar). The present report is concerned with the phosphorylation of p47PHOX Ser303 and Ser304 in relation to the activation of the leukocyte NADPH oxidase. The mutants p47PHOX S303A/S304A, S303D/S304D, S303E/S304E, and S315A/S320A were constructed by single strand mutagenesis of the p47PHOX cDNA as described previously (8Faust L.P. El Benna J. Babior B.M. Chanock S.J. J. Clin. Invest. 1995; 96: 1499-1505Crossref PubMed Scopus (155) Google Scholar). Mutagenesis was performed on cDNA cloned into pBluescript II KS+. The mutated cDNAs were then subcloned into the mammalian expression vector EBOpLPP. Mutations that altered the sequence of the protein were accompanied by silent mutations of nearby restriction sites, introduced to aid in screening. The mutations were confirmed by sequencing in the departmental facility. The S303K/S304K, S303A/S304E, and S303E/S304A mutations were constructed by a PCR 1The abbreviations used are: PCR, polymerase chain reaction; WT, wild-type; EBV, Epstein-Barr virus. strategy. In each case, the 5′ end of the “forward” primer spanned a unique NarI site 16 bases upstream of the 303 codon, the appropriately altered 303 and 304 codons, and 18 additional bases of native downstream sequence. A 19-base “reverse” primer that spanned an NaeI site about 180 base pairs downstream from the 304 codon was used for all three PCR mutagenesis reactions. PCR was performed with Pfu polymerase (Stratagene) using the wild-type p47PHOX cDNA as template. The PCR products were isolated from agarose gels using QIAEXII (Qiagen) and digested withNarI and NaeI. The resulting fragments were ligated into the NarI and NaeI sites of the p47PHOX S303A/S304A plasmid, a procedure that introduced the desired mutation into the product and destroyed a BssHII site that was introduced during the construction of the p47PHOX S303A/S304A cDNA. All PCR mutations were confirmed and the constructs documented to be error-free by sequencing across the fullNarI-NaeI span. Table I lists the primers and plasmids used in preparing the p47PHOX mutants.Table IMutagenesis of p47PHOXMutationOligonucleotideTemplate plasmidRestriction site changeSingle-strand mutagenesis (antisense oligonucleotide) S303A/S304ACG GAT GGC CGC GCG CCG GGG CGG CGCWT+ BssHII S303D/S304DCG GAT TTC TTC GCG CCG GGS303A/S304A−BssHII S303E/S304ECG GAT GTC GTC GCG CCG GGS303A/S304A−BssHII S315A/S320AATA GGC GTC CTG GGC GAG GCG CTT CCG CGC GCS320A+ EcoNIPCR mutagenesis (template WT1-aWT, wild-type. p47PHOX; −BssHI): S303A/S304EGGG GCG CCG CCC CGC AGG GCG GAA ATC CGC AAC GCG CAC AGC S303E/S304AGGG GCG CCG CCC CGC AGG GAA GCG ATC CGC AAC GCG CAC AGC S303A/S304KGGG GCG CCG CCC CGC AGG AAA AAG ATC CGC AAC GCG CAC AGC Reverse primerAT CGC CGG CTG CGG TTT AG1-a WT, wild-type. Open table in a new tab EBV-transformed p47PHOX-deficient B lymphocytes were co-transfected with SV40 plus wild-type or mutant p47PHOX expression vectors as indicated, and expanded under hygromycin selection as described previously (8Faust L.P. El Benna J. Babior B.M. Chanock S.J. J. Clin. Invest. 1995; 96: 1499-1505Crossref PubMed Scopus (155) Google Scholar), except that the p47PHOX-deficient cells were maintained at 0.5–1.0 × 106/ml before transfection and 106 cells/ml after transfection. Transfected cells were assayed only when fewer than 10% of the cells took up trypan blue. The cell line used for these experiments contained an uncharacterized mutation in the p47PHOX gene that prevented the expression of p47PHOX. Leukocyte NADPH oxidase activity was measured by chemiluminescence. Assays using whole cells were carried out as described elsewhere (11Thrasher A. Chetty M. Casimir C. Segal A.W. Blood. 1992; 80: 1125-1129Crossref PubMed Google Scholar), except that 4 × 106 cells and 10 IU of horseradish peroxidase were used in a final volume of 0.35 ml. The cell suspensions were placed in a 96-well microplate, warmed to 37 °C, then activated at the same temperature with phorbol myristate acetate (1 μg/ml). Chemiluminescence was then measured at 1-min intervals using a Luminoskan luminometer (Labsystems Research, Finland) at 37 °C. For measurement of leukocyte NADPH oxidase activity in a cell-free system, reaction mixtures contained 1.6 × 106 cell equivalents of neutrophil membranes, 9 × 106 cell equivalents of B lymphocyte cytosol, 1 mm luminol, 5 IU of horseradish peroxidase, 90 μm SDS, 160 μmNADPH, and Hanks' balanced salt solution containing 0.5 mmCaCl2 and 1 mm MgCl2, with or without 50 IU of superoxide dismutase, in final volume of 1 ml. Cytosol was prepared by sonicating a suspension of lymphoblasts in Dulbecco's phosphate-buffered saline for three 10-s intervals at 4 °C, then removing particles by centrifugation for 15 min at the same temperature in an Eppendorf Microfuge. Initially, the assay mixture contained all the components except SDS and NADPH. The oxidase was then activated by adding SDS and incubating for 1 min at room temperature. O·̄2production was then initiated with NADPH, and chemiluminescence was measured at successive 10-s interval using a Luminoskan luminometer at room temperature. The expression of p47PHOX in the transfected cells and the translocation of p47PHOX from cytosol to membranes was determined by immunoblotting (8Faust L.P. El Benna J. Babior B.M. Chanock S.J. J. Clin. Invest. 1995; 96: 1499-1505Crossref PubMed Scopus (155) Google Scholar). Fractions were subjected to SDS-polyacrylamide gel electrophoresis on 10% polyacrylamide gels using the Laemmli buffer system. The separated proteins were electrophoretically transferred onto a nitrocellulose membrane, which was blocked with Blotto and probed with a 1:5000 dilution of an antibody against the C-terminal decapeptide of WT p47PHOX. In measurements of p47PHOX expression in whole cells, p47PHOX on the immunoblots was visualized with alkaline phosphatase-labeled goat anti-rabbit immunoglobulin antibodies followed by visualization with the 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium detection system (12Park J.-W. Ma M. Ruedi J.M. Smith R.M. Babior B.M. J. Biol. Chem. 1992; 267: 17327-17332Abstract Full Text PDF PubMed Google Scholar). Expression was measured by densitometry with a Zeinieh laser scanner, determining relative quantities of p47PHOX from peak heights. In the translocation experiments, peroxidase-labeled goat anti-rabbit immunoglobulin antibodies and the ECL chemiluminescence detection system (Renaissance; DuPont, Boston, MA) were used for the visualization of p47PHOX. In prior studies, we have shown that the activation of the leukocyte NADPH oxidase in neutrophils and EBV-transformed B lymphocytes is accompanied by the phosphorylation of serines 303 and 304 in the cytosolic oxidase component p47PHOX (7el Benna J. Faust L.P. Babior B.M. J. Biol. Chem. 1994; 269: 23431-23436Abstract Full Text PDF PubMed Google Scholar). Consistent with the possibility that the phosphorylation of these serines is involved in oxidase activation, we reported that the conversion of either Ser303 or Ser304 to alanine resulted in a >50% decrease in O·̄2 production by EBV-transformed lymphocytes expressing the mutant p47PHOX proteins (8Faust L.P. El Benna J. Babior B.M. Chanock S.J. J. Clin. Invest. 1995; 96: 1499-1505Crossref PubMed Scopus (155) Google Scholar). For the individual serines these decreases were not statistically significant (p > 0.05), but a level of significance of p < 0.004 was achieved when the results were reanalyzed under the hypothesis that the loss of either one of these serines resulted in a decrease in O·̄2 production (Wilcoxon rank sum test). This analysis suggested that the phosphorylation of at least one of these serines was necessary for oxidase activation in EBV-transformed B lymphocytes. To test this possibility, O·̄2 production was measured in p47PHOX-deficient EBV-transformed B lymphocytes expressing p47PHOX with a number of double mutations at positions Ser303 and Ser304. Time courses for O·̄2production by untransformed B lymphocytes and by cells expressing wild-type or mutant forms of p47PHOX are illustrated in Fig. 1; peak chemiluminescence values for the same cells are shown in Fig. 2. Inspection of the results obtained with the mutant in which serines 303 and 304 were converted to alanines showed that O·̄2 production was nearly abolished by these mutations, supporting the idea that the phosphorylation of at least one of these serines is required for oxidase activation. A second double Ser → Ala mutant, p47PHOX S310A/S315A, was fully active, indicating that the mere replacement with alanines of 2 serines in the region of the phosphorylation targets was not enough to abolish the activity of p47PHOX.Figure 2Oxidase activity of phorbol-activated p47PHOX-deficient B cells expressing WT and mutant forms of recombinant p47PHOX. Experiments were carried out as described in the text. The results represent peak luminescence by transfected p47PHOX-deficient B cells expressing different forms of p47PHOX. The results are expressed as % of WT control, and are presented as the mean ± 1 S.D. of three or more separate sets of transfections. Peak chemiluminescence for cells expressing the WT protein was 6.2 ± 0.4 Luminoskan units.View Large Image Figure ViewerDownload (PPT) Further support for this idea was obtained when these two serines were replaced, not with alanines, but with negatively charged residues. One of the effects of serine phosphorylation is the introduction of negative charge in a region of a polypeptide that was originally uncharged. Negative charge can also be introduced by replacing a serine with an aspartate or glutamate residue, and in fact studies on other proteins activated by serine phosphorylation have shown that the replacement of a phosphorylated serine with an aspartate residue can have the same functional consequences as the phosphorylation of that serine (13Hurley J.H. Dean A.M. Sohl J.L. Koshland Jr., D.E. Stroud R.M. Science. 1990; 249: 1012-1016Crossref PubMed Scopus (210) Google Scholar). To ascertain whether the introduction of negative charge in the vicinity of p47PHOX Ser303-Ser304 had the same effect on oxidase activity as the phosphorylation of serines 303 and 304, we measured O·̄2 production in EBV-transformed B lymphocytes expressing the p47PHOX double mutants S303D/S304D and S303E/S304E. The results showed that, in contrast to the double p47PHOX mutant S303A/S304A, the glutamate mutant was able to support O·̄2production. In cells that expressed p47PHOX S303E/S304E, oxidase activation (Fig. 1) and maximum rates of O·̄2 production (Fig. 2) were both similar to their counterparts in cells transfected with WT p47PHOX. On the other hand, the results obtained with the cells transfected with p47PHOX S303D/S304D were equivocal, not an unexpected outcome given that in steric terms, p47PHOX S303S/S304S-OPO3= is much more similar to p47PHOX S303E/S304E than to p47PHOX S303D/S304D. Replacement of one of the two serines with glutamate and the other with alanine led to p47PHOX mutants that supported O·̄2production to the extent of about 25% of wild-type levels, a finding consistent with earlier work showing that mutants in which one of the two serines was replaced by alanine and the other was left alone were able to support O·̄2 production, but at reduced levels (8Faust L.P. El Benna J. Babior B.M. Chanock S.J. J. Clin. Invest. 1995; 96: 1499-1505Crossref PubMed Scopus (155) Google Scholar). One possible explanation for the inability of cells transfected with the S303A/S304A mutant to generate O·̄2 is that the EBV-transformed p47PHOX-deficient B cells were unable to express p47PHOX S303A/S304A, the mutant that failed to support O·̄2 production. The findings presented in Fig. 3 and Table II, however, show that all the mutant forms of p47PHOX examined in these experiments were expressed to approximately the same extent as the WT protein. The inability of p47PHOX S303A/S304A to support O·̄2 production therefore could not be attributed to a failure of expression by the transfected cells. A second possible explanation is that, although fully expressed, p47PHOX S303A/S304A could not fold into a native conformation, and was therefore unable to participate in the activation of the leukocyte NADPH oxidase. To investigate this possibility, we examined the ability of the mutant forms of p47PHOX to support O·̄2 production in a cell-free system in which activation was accomplished by an anionic detergent (in this case, SDS), not phosphorylation. Fig. 4 shows that there was little difference in O·̄2 production among cell-free systems containing the various forms of p47PHOX. In particular, the cell-free system that contained p47PHOX S303A/S304A produced O·̄2 at the same rate as the system that contained WT p47PHOX. Therefore the conformation of p47PHOX S303A/S304A was sufficiently similar to the native conformation that the mutant protein functioned normally in the cell-free oxidase activating system, even though it was inactive in whole cells.Table IIExpression of p47PHOX mutants in transfected p47PHOX-deficient B lymphocytes relative to the expression of the wild-type proteinp47PHOXExpression% wild typenWT1006S303A/S304A94.7 ± 4.76S303D/S304D82.8 ± 9.26S303E/S304E72.9 ± 13.54S310A/S315A89.9 ± 5.23S303A/S304E84.6 ± 4.92S303E/S304A92.7 ± 7.82S303K/S304K97.3 ± 6.42 Open table in a new tab Figure 4Oxidase activity in a cell-free oxidase activating system containing WT and mutant forms of recombinant p47PHOX. Assays were carried out as described under “Materials and Methods.” Results shown are the differences between luminescence values measured in the absence and presence of 50 units of superoxide dismutase; the latter values never exceeded 5% of the former. The results were calculated from the peak luminescence values observed with each form of p47PHOX, and are shown as % of WT control (mean ± range of duplicate experiments). Control values were 24.5 ± 3.4 Luminoskan units.View Large Image Figure ViewerDownload (PPT) Activation of the leukocyte NADPH oxidase is accompanied by the translocation of the oxidase components p47PHOX and p67PHOX from the cytosol to the plasma membrane, where they associate with the flavocytochrome b558 (2Heyworth P.G. Curnutte J.T. Nauseef W.M. Volpp B.D. Pearson D.W. Rosen H. Clark R.A. J. Clin. Invest. 1991; 87: 352-356Crossref PubMed Scopus (305) Google Scholar, 14Rotrosen D. Kleinberg M.E. Nunoi H. Leto T. Gallin J.I. Malech H.L. J. Biol. Chem. 1990; 265: 8745-8750Abstract Full Text PDF PubMed Google Scholar). This association is thought to result at least in part from the appearance of a membrane-binding site on p47PHOX when the oxidase is activated (12Park J.-W. Ma M. Ruedi J.M. Smith R.M. Babior B.M. J. Biol. Chem. 1992; 267: 17327-17332Abstract Full Text PDF PubMed Google Scholar, 15Nakanishi A. Imajoh-Ohmi S. Fujinawa T. Kikuchi H. Kanegasaki S. J. Biol. Chem. 1992; 267: 19072-19074Abstract Full Text PDF PubMed Google Scholar). We found that when p47PHOX-deficient cells expressing the double mutants p47PHOX S303A/S304A, p47PHOX S303D/S304D, or p47PHOX S303E/S304E were activated with phorbol ester, the mutant p47PHOX polypeptides were transferred to the plasma membrane as efficiently as the WT protein (Fig. 5). The finding that p47PHOX S303A/S304A translocates normally suggests that a negative electrostatic potential in the vicinity of residues 303–304 is not needed for the binding of p47PHOX to the flavocytochrome, although it is required for the enzyme to express its catalytic activity. Besides adding local negative charge to p47PHOX, the phosphorylation of serines 303 and 304 causes a large increase in the polarity of the polypeptide in the vicinity of those residues. To determine whether the effect of phosphorylation on oxidase activity was due to the negative electrostatic potential or the increase in polarity, we examined the activity of the mutant p47PHOX S303K/S304K, in which residues 303 and 304 carry positive, not negative, charges. The translocation of this mutant was normal (Fig. 6), and its activity was normal as well, somewhat to our surprise (Figs. 1 and 2). Therefore the function of the Ser303 and Ser304phosphates in the activation of the oxidase must be related to more than simply the acquisition of negative charge by the serine 303–304 region of p47PHOX. In an earlier study of 11 p47PHOX mutants containing an alanine instead of a serine at a single potential phosphorylation site, we found that all but p47PHOX S379A were active when expressed in EBV-transformed p47PHOX-deficient B cells (8Faust L.P. El Benna J. Babior B.M. Chanock S.J. J. Clin. Invest. 1995; 96: 1499-1505Crossref PubMed Scopus (155) Google Scholar). Therefore, apart from serine 379, no single phosphorylation site appeared to be essential for oxidase activation. As to Ser379, its state of phosphorylation in the activated oxidase is unclear: it became phosphorylated only to a very limited extent when neutrophils were activated, and p47PHOX S379D was no more active than p47PHOX S379A in the p47PHOX-deficient cells. 2L. P. Faust and B. M. Babior, unpublished observation. Consequently, it was not possible to be absolutely certain from those results whether or not the phosphorylation of p47PHOX, either at Ser379 or at any other potential phosphorylation site, was required for the activation of the oxidase. Unlike Ser379, serines 303 and 304 are extensively phosphorylated during oxidase activation (7el Benna J. Faust L.P. Babior B.M. J. Biol. Chem. 1994; 269: 23431-23436Abstract Full Text PDF PubMed Google Scholar, 9El Benna J. Faust L.P. Johnson J.L. Babior B.M. J. Biol. Chem. 1996; 271: 6374-6378Abstract Full Text Full Text PDF PubMed Scopus (207) Google Scholar). In earlier work, we found that the oxidase could still be activated if either serines 303 or 304 were converted to alanine (8Faust L.P. El Benna J. Babior B.M. Chanock S.J. J. Clin. Invest. 1995; 96: 1499-1505Crossref PubMed Scopus (155) Google Scholar). The present results, however, show that if both of these serines are converted to alanine, the activation of the oxidase is almost completely abolished. These findings provide direct evidence that the phosphorylation of at least one of the serines of p47PHOX, specifically, serines 303 or 304, is necessary for the activation of the leukocyte NADPH oxidase. Our results support similar conclusions drawn from earlier studies showing that p47PHOX is phosphorylated when the oxidase is activated by a variety of stimuli (3Hayakawa T. Suzuki K. Suzuki S. Andrews P.C. Babior B.M. J. Biol. Chem. 1986; 261: 9109-9115Abstract Full Text PDF PubMed Google Scholar, 5Caldwell S.E. McCall C.E. Hendricks C.L. Leone P.A. Bass D.A. McPhail L.C. J. Clin. Invest. 1988; 81: 1485-1496Crossref PubMed Scopus (61) Google Scholar, 6Rotrosen D. Leto T.L. J. Biol. Chem. 1990; 265: 19910-19915Abstract Full Text PDF PubMed Google Scholar, 7el Benna J. Faust L.P. Babior B.M. J. Biol. Chem. 1994; 269: 23431-23436Abstract Full Text PDF PubMed Google Scholar); that various protein kinase inhibitors can diminish or prevent O·̄2 production (16Heyworth P.G. Erickson R.W. Ding J.B. Curnutte J.T. Badwey J.A. Biochem. J. 1995; 311: 81-87Crossref PubMed Scopus (13) Google Scholar, 17Arai M. Sasaki Y. Nozawa R. Biochem. Pharmacol. 1993; 46: 1487-1490Crossref PubMed Scopus (40) Google Scholar, 18Twomey B. Muid R.E. Dale M.M. Br. J. Pharmacol. 1990; 100: 819-825Crossref PubMed Scopus (36) Google Scholar) while protein phosphatase inhibitors augment O·̄2production (19Ding J. Badwey J.A. J. Biol. Chem. 1992; 267: 6442-6448Abstract Full Text PDF PubMed Google Scholar, 20Steinbeck M.J. Hegg G.G. Karnovsky M.J. J. Biol. Chem. 1991; 266: 16336-16342Abstract Full Text PDF PubMed Google Scholar, 21Garcia R.C. Whitaker M. Heyworth P.G. Segal A.W. Biochem. J. 1992; 286: 687-692Crossref PubMed Scopus (39) Google Scholar, 22Djerdjouri B. Combadière C. Pedruzzi E. Hakim J. Périanin A. Eur. J. Pharmacol. Mol. Pharmacol. 1995; 288: 193-200Crossref PubMed Scopus (19) Google Scholar, 23Suzuki K. Yamaguchi T. Oshizawa T. Yamamoto Y. Nishimaki-Mogami T. Hayakawa T. Takahashi A. Biochim. Biophys. Acta. 1995; 1266: 261-267Crossref PubMed Scopus (30) Google Scholar); and that recombinant p47PHOX phosphorylated by protein kinase C can activate the oxidase in the cell-free system in the absence of added detergents (24El Benna J. Park J.-W. Ruedi J.M. Babior B.M. Blood Cells Mol. Dis. 1995; 21: 201-206Crossref PubMed Scopus (32) Google Scholar, 25Park J.-W. Ahn S.M. Biochem. Biophys. Res. Commun. 1995; 211: 410-416Crossref PubMed Scopus (29) Google Scholar, 26Park J.-W. Hoyal C.R. El Benna J. Babior B.M. J. Biol. Chem. 1997; 272: 11035-11043Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar). The effect of the serine-to-alanine mutations is to substitute methyl groups for two of the hydroxymethyl groups known to be phosphorylated during oxidase activation in whole cells (7el Benna J. Faust L.P. Babior B.M. J. Biol. Chem. 1994; 269: 23431-23436Abstract Full Text PDF PubMed Google Scholar). The conversion of these serines to alanines destroyed the activity of p47PHOX. In contrast, the conversion of the same serines to glutamate, a mutation that substituted negatively charged carboxymethyl groups for the two hydroxymethyl groups, gave rise to mutant protein with considerable activity. Since the phosphorylation of other serines in p47PHOX was unaffected by the elimination of serines 303 and 304 (9El Benna J. Faust L.P. Johnson J.L. Babior B.M. J. Biol. Chem. 1996; 271: 6374-6378Abstract Full Text Full Text PDF PubMed Scopus (207) Google Scholar), the simplest explanation for all these findings is that oxidase activation in whole cells requires a negative electrostatic potential in the vicinity of serines 303 and 304 of p47PHOX, and that this potential is generated through the phosphorylation of one or both of those serines. The results with the S303K/S304K mutant, however, indicate that the acquisition of a negative electrostatic potential is not a sufficient explanation. They suggest instead that the purpose of the phosphorylation of Ser303 and Ser304 may be to change the polarity of the protein in the neighborhood of those serines. Alternatively, they may indicate that the phosphates are there to bind divalent metals such as Mg2+, an action that would confer on the serine 303–304 region a net positive charge similar to that in the S303K/S304K mutant. How can these local effects promote the activity of the leukocyte NADPH oxidase? Because the mutants all translocate normally, it is clear that phosphorylation at Ser303-Ser304 is not an obligatory precursor of translocation. In principle, then, phosphorylation at these positions can take place either before or after the translocation of p47PHOX to the membrane. Earlier evidence showing that the final 1 or 2 phosphorylations take place after translocation (6Rotrosen D. Leto T.L. J. Biol. Chem. 1990; 265: 19910-19915Abstract Full Text PDF PubMed Google Scholar) suggests that at least some p47PHOX is phosphorylated after it is transferred from the cytosol to the membrane. It seems likely that the phosphorylation of Ser303 and Ser304 converts the membrane-bound subunit into a form that is able to render the oxidase catalytically active." @default.
- W1968542957 created "2016-06-24" @default.
- W1968542957 creator A5005439270 @default.
- W1968542957 creator A5007968139 @default.
- W1968542957 creator A5014280478 @default.
- W1968542957 creator A5039679762 @default.
- W1968542957 creator A5053928945 @default.
- W1968542957 creator A5065215242 @default.
- W1968542957 creator A5079105055 @default.
- W1968542957 date "1998-04-01" @default.
- W1968542957 modified "2023-10-09" @default.
- W1968542957 title "Activation of the Leukocyte NADPH Oxidase by Phorbol Ester Requires the Phosphorylation of p47 on Serine 303 or 304" @default.
- W1968542957 cites W1486414742 @default.
- W1968542957 cites W1497341558 @default.
- W1968542957 cites W1503444337 @default.
- W1968542957 cites W1510633031 @default.
- W1968542957 cites W1523615229 @default.
- W1968542957 cites W1541070883 @default.
- W1968542957 cites W1550046238 @default.
- W1968542957 cites W1558113022 @default.
- W1968542957 cites W1566587067 @default.
- W1968542957 cites W1595045594 @default.
- W1968542957 cites W1777726345 @default.
- W1968542957 cites W1967942767 @default.
- W1968542957 cites W1981857743 @default.
- W1968542957 cites W1985042912 @default.
- W1968542957 cites W2003757232 @default.
- W1968542957 cites W2010027411 @default.
- W1968542957 cites W2011039500 @default.
- W1968542957 cites W2034453407 @default.
- W1968542957 cites W2050768620 @default.
- W1968542957 cites W2083453155 @default.
- W1968542957 cites W2086903864 @default.
- W1968542957 cites W2114973469 @default.
- W1968542957 cites W2151683047 @default.
- W1968542957 cites W2168308945 @default.
- W1968542957 cites W2202455708 @default.
- W1968542957 cites W2399244463 @default.
- W1968542957 doi "https://doi.org/10.1074/jbc.273.16.9539" @default.
- W1968542957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9545283" @default.
- W1968542957 hasPublicationYear "1998" @default.
- W1968542957 type Work @default.
- W1968542957 sameAs 1968542957 @default.
- W1968542957 citedByCount "168" @default.
- W1968542957 countsByYear W19685429572012 @default.
- W1968542957 countsByYear W19685429572013 @default.
- W1968542957 countsByYear W19685429572014 @default.
- W1968542957 countsByYear W19685429572015 @default.
- W1968542957 countsByYear W19685429572016 @default.
- W1968542957 countsByYear W19685429572017 @default.
- W1968542957 countsByYear W19685429572018 @default.
- W1968542957 countsByYear W19685429572019 @default.
- W1968542957 countsByYear W19685429572020 @default.
- W1968542957 countsByYear W19685429572021 @default.
- W1968542957 countsByYear W19685429572022 @default.
- W1968542957 countsByYear W19685429572023 @default.
- W1968542957 crossrefType "journal-article" @default.
- W1968542957 hasAuthorship W1968542957A5005439270 @default.
- W1968542957 hasAuthorship W1968542957A5007968139 @default.
- W1968542957 hasAuthorship W1968542957A5014280478 @default.
- W1968542957 hasAuthorship W1968542957A5039679762 @default.
- W1968542957 hasAuthorship W1968542957A5053928945 @default.
- W1968542957 hasAuthorship W1968542957A5065215242 @default.
- W1968542957 hasAuthorship W1968542957A5079105055 @default.
- W1968542957 hasBestOaLocation W19685429571 @default.
- W1968542957 hasConcept C11960822 @default.
- W1968542957 hasConcept C181199279 @default.
- W1968542957 hasConcept C185592680 @default.
- W1968542957 hasConcept C195794163 @default.
- W1968542957 hasConcept C2776414213 @default.
- W1968542957 hasConcept C2779719074 @default.
- W1968542957 hasConcept C3017695315 @default.
- W1968542957 hasConcept C55493867 @default.
- W1968542957 hasConcept C86803240 @default.
- W1968542957 hasConcept C95444343 @default.
- W1968542957 hasConceptScore W1968542957C11960822 @default.
- W1968542957 hasConceptScore W1968542957C181199279 @default.
- W1968542957 hasConceptScore W1968542957C185592680 @default.
- W1968542957 hasConceptScore W1968542957C195794163 @default.
- W1968542957 hasConceptScore W1968542957C2776414213 @default.
- W1968542957 hasConceptScore W1968542957C2779719074 @default.
- W1968542957 hasConceptScore W1968542957C3017695315 @default.
- W1968542957 hasConceptScore W1968542957C55493867 @default.
- W1968542957 hasConceptScore W1968542957C86803240 @default.
- W1968542957 hasConceptScore W1968542957C95444343 @default.
- W1968542957 hasIssue "16" @default.
- W1968542957 hasLocation W19685429571 @default.
- W1968542957 hasOpenAccess W1968542957 @default.
- W1968542957 hasPrimaryLocation W19685429571 @default.
- W1968542957 hasRelatedWork W1978122481 @default.
- W1968542957 hasRelatedWork W2040050327 @default.
- W1968542957 hasRelatedWork W2057779043 @default.
- W1968542957 hasRelatedWork W2073434252 @default.
- W1968542957 hasRelatedWork W2074613314 @default.
- W1968542957 hasRelatedWork W2125033869 @default.
- W1968542957 hasRelatedWork W2286885533 @default.
- W1968542957 hasRelatedWork W2300735653 @default.
- W1968542957 hasRelatedWork W34961730 @default.